Global Low Molecular Weight Heparin Sodium Market Insights and Forecast to 2028

Report ID: 1156422 | Published Date: Jan 2025 | No. of Page: 97 | Base Year: 2024 | Rating: 3.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Low Molecular Weight Heparin Sodium Product Introduction
    1.2 Market by Type
        1.2.1 Global Low Molecular Weight Heparin Sodium Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Enoxaparin
        1.2.3 Dalteparin
        1.2.4 Tinzaparin
        1.2.5 Fraxiparine
    1.3 Market by Application
        1.3.1 Global Low Molecular Weight Heparin Sodium Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Medical
        1.3.3 Research
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Low Molecular Weight Heparin Sodium Sales Estimates and Forecasts 2017-2028
    2.2 Global Low Molecular Weight Heparin Sodium Revenue Estimates and Forecasts 2017-2028
    2.3 Global Low Molecular Weight Heparin Sodium Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Low Molecular Weight Heparin Sodium Sales by Region
        2.4.1 Global Low Molecular Weight Heparin Sodium Sales by Region (2017-2022)
        2.4.2 Global Sales Low Molecular Weight Heparin Sodium by Region (2023-2028)
    2.5 Global Low Molecular Weight Heparin Sodium Revenue by Region
        2.5.1 Global Low Molecular Weight Heparin Sodium Revenue by Region (2017-2022)
        2.5.2 Global Low Molecular Weight Heparin Sodium Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Low Molecular Weight Heparin Sodium Sales by Manufacturers
        3.1.1 Global Top Low Molecular Weight Heparin Sodium Manufacturers by Sales (2017-2022)
        3.1.2 Global Low Molecular Weight Heparin Sodium Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Low Molecular Weight Heparin Sodium in 2021
    3.2 Global Low Molecular Weight Heparin Sodium Revenue by Manufacturers
        3.2.1 Global Low Molecular Weight Heparin Sodium Revenue by Manufacturers (2017-2022)
        3.2.2 Global Low Molecular Weight Heparin Sodium Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Low Molecular Weight Heparin Sodium Revenue in 2021
    3.3 Global Low Molecular Weight Heparin Sodium Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Low Molecular Weight Heparin Sodium Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Low Molecular Weight Heparin Sodium Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Low Molecular Weight Heparin Sodium Sales by Type
        4.1.1 Global Low Molecular Weight Heparin Sodium Historical Sales by Type (2017-2022)
        4.1.2 Global Low Molecular Weight Heparin Sodium Forecasted Sales by Type (2023-2028)
        4.1.3 Global Low Molecular Weight Heparin Sodium Sales Market Share by Type (2017-2028)
    4.2 Global Low Molecular Weight Heparin Sodium Revenue by Type
        4.2.1 Global Low Molecular Weight Heparin Sodium Historical Revenue by Type (2017-2022)
        4.2.2 Global Low Molecular Weight Heparin Sodium Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Low Molecular Weight Heparin Sodium Revenue Market Share by Type (2017-2028)
    4.3 Global Low Molecular Weight Heparin Sodium Price by Type
        4.3.1 Global Low Molecular Weight Heparin Sodium Price by Type (2017-2022)
        4.3.2 Global Low Molecular Weight Heparin Sodium Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Low Molecular Weight Heparin Sodium Sales by Application
        5.1.1 Global Low Molecular Weight Heparin Sodium Historical Sales by Application (2017-2022)
        5.1.2 Global Low Molecular Weight Heparin Sodium Forecasted Sales by Application (2023-2028)
        5.1.3 Global Low Molecular Weight Heparin Sodium Sales Market Share by Application (2017-2028)
    5.2 Global Low Molecular Weight Heparin Sodium Revenue by Application
        5.2.1 Global Low Molecular Weight Heparin Sodium Historical Revenue by Application (2017-2022)
        5.2.2 Global Low Molecular Weight Heparin Sodium Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Low Molecular Weight Heparin Sodium Revenue Market Share by Application (2017-2028)
    5.3 Global Low Molecular Weight Heparin Sodium Price by Application
        5.3.1 Global Low Molecular Weight Heparin Sodium Price by Application (2017-2022)
        5.3.2 Global Low Molecular Weight Heparin Sodium Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Low Molecular Weight Heparin Sodium Market Size by Type
        6.1.1 North America Low Molecular Weight Heparin Sodium Sales by Type (2017-2028)
        6.1.2 North America Low Molecular Weight Heparin Sodium Revenue by Type (2017-2028)
    6.2 North America Low Molecular Weight Heparin Sodium Market Size by Application
        6.2.1 North America Low Molecular Weight Heparin Sodium Sales by Application (2017-2028)
        6.2.2 North America Low Molecular Weight Heparin Sodium Revenue by Application (2017-2028)
    6.3 North America Low Molecular Weight Heparin Sodium Market Size by Country
        6.3.1 North America Low Molecular Weight Heparin Sodium Sales by Country (2017-2028)
        6.3.2 North America Low Molecular Weight Heparin Sodium Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Low Molecular Weight Heparin Sodium Market Size by Type
        7.1.1 Europe Low Molecular Weight Heparin Sodium Sales by Type (2017-2028)
        7.1.2 Europe Low Molecular Weight Heparin Sodium Revenue by Type (2017-2028)
    7.2 Europe Low Molecular Weight Heparin Sodium Market Size by Application
        7.2.1 Europe Low Molecular Weight Heparin Sodium Sales by Application (2017-2028)
        7.2.2 Europe Low Molecular Weight Heparin Sodium Revenue by Application (2017-2028)
    7.3 Europe Low Molecular Weight Heparin Sodium Market Size by Country
        7.3.1 Europe Low Molecular Weight Heparin Sodium Sales by Country (2017-2028)
        7.3.2 Europe Low Molecular Weight Heparin Sodium Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Low Molecular Weight Heparin Sodium Market Size by Type
        8.1.1 Asia Pacific Low Molecular Weight Heparin Sodium Sales by Type (2017-2028)
        8.1.2 Asia Pacific Low Molecular Weight Heparin Sodium Revenue by Type (2017-2028)
    8.2 Asia Pacific Low Molecular Weight Heparin Sodium Market Size by Application
        8.2.1 Asia Pacific Low Molecular Weight Heparin Sodium Sales by Application (2017-2028)
        8.2.2 Asia Pacific Low Molecular Weight Heparin Sodium Revenue by Application (2017-2028)
    8.3 Asia Pacific Low Molecular Weight Heparin Sodium Market Size by Region
        8.3.1 Asia Pacific Low Molecular Weight Heparin Sodium Sales by Region (2017-2028)
        8.3.2 Asia Pacific Low Molecular Weight Heparin Sodium Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 China Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
9 Latin America
    9.1 Latin America Low Molecular Weight Heparin Sodium Market Size by Type
        9.1.1 Latin America Low Molecular Weight Heparin Sodium Sales by Type (2017-2028)
        9.1.2 Latin America Low Molecular Weight Heparin Sodium Revenue by Type (2017-2028)
    9.2 Latin America Low Molecular Weight Heparin Sodium Market Size by Application
        9.2.1 Latin America Low Molecular Weight Heparin Sodium Sales by Application (2017-2028)
        9.2.2 Latin America Low Molecular Weight Heparin Sodium Revenue by Application (2017-2028)
    9.3 Latin America Low Molecular Weight Heparin Sodium Market Size by Country
        9.3.1 Latin America Low Molecular Weight Heparin Sodium Sales by Country (2017-2028)
        9.3.2 Latin America Low Molecular Weight Heparin Sodium Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Low Molecular Weight Heparin Sodium Market Size by Type
        10.1.1 Middle East and Africa Low Molecular Weight Heparin Sodium Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Low Molecular Weight Heparin Sodium Revenue by Type (2017-2028)
    10.2 Middle East and Africa Low Molecular Weight Heparin Sodium Market Size by Application
        10.2.1 Middle East and Africa Low Molecular Weight Heparin Sodium Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Low Molecular Weight Heparin Sodium Revenue by Application (2017-2028)
    10.3 Middle East and Africa Low Molecular Weight Heparin Sodium Market Size by Country
        10.3.1 Middle East and Africa Low Molecular Weight Heparin Sodium Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Low Molecular Weight Heparin Sodium Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Aspen
        11.1.1 Aspen Corporation Information
        11.1.2 Aspen Overview
        11.1.3 Aspen Low Molecular Weight Heparin Sodium Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Aspen Low Molecular Weight Heparin Sodium Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Aspen Recent Developments
    11.2 Sanofi-aventis
        11.2.1 Sanofi-aventis Corporation Information
        11.2.2 Sanofi-aventis Overview
        11.2.3 Sanofi-aventis Low Molecular Weight Heparin Sodium Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Sanofi-aventis Low Molecular Weight Heparin Sodium Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Sanofi-aventis Recent Developments
    11.3 Pfizer
        11.3.1 Pfizer Corporation Information
        11.3.2 Pfizer Overview
        11.3.3 Pfizer Low Molecular Weight Heparin Sodium Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Pfizer Low Molecular Weight Heparin Sodium Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Pfizer Recent Developments
    11.4 Opocrin
        11.4.1 Opocrin Corporation Information
        11.4.2 Opocrin Overview
        11.4.3 Opocrin Low Molecular Weight Heparin Sodium Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Opocrin Low Molecular Weight Heparin Sodium Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Opocrin Recent Developments
    11.5 CSBIO
        11.5.1 CSBIO Corporation Information
        11.5.2 CSBIO Overview
        11.5.3 CSBIO Low Molecular Weight Heparin Sodium Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 CSBIO Low Molecular Weight Heparin Sodium Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 CSBIO Recent Developments
    11.6 Dongying Tiandong Pharmaceutica
        11.6.1 Dongying Tiandong Pharmaceutica Corporation Information
        11.6.2 Dongying Tiandong Pharmaceutica Overview
        11.6.3 Dongying Tiandong Pharmaceutica Low Molecular Weight Heparin Sodium Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Dongying Tiandong Pharmaceutica Low Molecular Weight Heparin Sodium Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Dongying Tiandong Pharmaceutica Recent Developments
    11.7 Changzhou Qianhong Bio-pharma
        11.7.1 Changzhou Qianhong Bio-pharma Corporation Information
        11.7.2 Changzhou Qianhong Bio-pharma Overview
        11.7.3 Changzhou Qianhong Bio-pharma Low Molecular Weight Heparin Sodium Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 Changzhou Qianhong Bio-pharma Low Molecular Weight Heparin Sodium Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Changzhou Qianhong Bio-pharma Recent Developments
    11.8 Techdow
        11.8.1 Techdow Corporation Information
        11.8.2 Techdow Overview
        11.8.3 Techdow Low Molecular Weight Heparin Sodium Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 Techdow Low Molecular Weight Heparin Sodium Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 Techdow Recent Developments
    11.9 Yantai Dongcheng Pharmaceutical Group
        11.9.1 Yantai Dongcheng Pharmaceutical Group Corporation Information
        11.9.2 Yantai Dongcheng Pharmaceutical Group Overview
        11.9.3 Yantai Dongcheng Pharmaceutical Group Low Molecular Weight Heparin Sodium Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 Yantai Dongcheng Pharmaceutical Group Low Molecular Weight Heparin Sodium Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 Yantai Dongcheng Pharmaceutical Group Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Low Molecular Weight Heparin Sodium Industry Chain Analysis
    12.2 Low Molecular Weight Heparin Sodium Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Low Molecular Weight Heparin Sodium Production Mode & Process
    12.4 Low Molecular Weight Heparin Sodium Sales and Marketing
        12.4.1 Low Molecular Weight Heparin Sodium Sales Channels
        12.4.2 Low Molecular Weight Heparin Sodium Distributors
    12.5 Low Molecular Weight Heparin Sodium Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Low Molecular Weight Heparin Sodium Industry Trends
    13.2 Low Molecular Weight Heparin Sodium Market Drivers
    13.3 Low Molecular Weight Heparin Sodium Market Challenges
    13.4 Low Molecular Weight Heparin Sodium Market Restraints
14 Key Findings in The Global Low Molecular Weight Heparin Sodium Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer

List of Tables
    Table 1. Global Low Molecular Weight Heparin Sodium Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Enoxaparin
    Table 3. Major Manufacturers of Dalteparin
    Table 4. Major Manufacturers of Tinzaparin
    Table 5. Major Manufacturers of Fraxiparine
    Table 6. Global Low Molecular Weight Heparin Sodium Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 7. Global Low Molecular Weight Heparin Sodium Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 8. Global Low Molecular Weight Heparin Sodium Sales by Region (2017-2022) & (K MT)
    Table 9. Global Low Molecular Weight Heparin Sodium Sales Market Share by Region (2017-2022)
    Table 10. Global Low Molecular Weight Heparin Sodium Sales by Region (2023-2028) & (K MT)
    Table 11. Global Low Molecular Weight Heparin Sodium Sales Market Share by Region (2023-2028)
    Table 12. Global Low Molecular Weight Heparin Sodium Revenue by Region (2017-2022) & (US$ Million)
    Table 13. Global Low Molecular Weight Heparin Sodium Revenue Market Share by Region (2017-2022)
    Table 14. Global Low Molecular Weight Heparin Sodium Revenue by Region (2023-2028) & (US$ Million)
    Table 15. Global Low Molecular Weight Heparin Sodium Revenue Market Share by Region (2023-2028)
    Table 16. Global Low Molecular Weight Heparin Sodium Sales by Manufacturers (2017-2022) & (K MT)
    Table 17. Global Low Molecular Weight Heparin Sodium Sales Share by Manufacturers (2017-2022)
    Table 18. Global Low Molecular Weight Heparin Sodium Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 19. Global Low Molecular Weight Heparin Sodium Revenue Share by Manufacturers (2017-2022)
    Table 20. Low Molecular Weight Heparin Sodium Price by Manufacturers (2017-2022) &(USD/MT)
    Table 21. Global Low Molecular Weight Heparin Sodium Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 22. Global Low Molecular Weight Heparin Sodium by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Low Molecular Weight Heparin Sodium as of 2021)
    Table 23. Low Molecular Weight Heparin Sodium Manufacturing Base Distribution and Headquarters
    Table 24. Manufacturers Low Molecular Weight Heparin Sodium Product Offered
    Table 25. Date of Manufacturers Enter into Low Molecular Weight Heparin Sodium Market
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Low Molecular Weight Heparin Sodium Sales by Type (2017-2022) & (K MT)
    Table 28. Global Low Molecular Weight Heparin Sodium Sales by Type (2023-2028) & (K MT)
    Table 29. Global Low Molecular Weight Heparin Sodium Sales Share by Type (2017-2022)
    Table 30. Global Low Molecular Weight Heparin Sodium Sales Share by Type (2023-2028)
    Table 31. Global Low Molecular Weight Heparin Sodium Revenue by Type (2017-2022) & (US$ Million)
    Table 32. Global Low Molecular Weight Heparin Sodium Revenue by Type (2023-2028) & (US$ Million)
    Table 33. Global Low Molecular Weight Heparin Sodium Revenue Share by Type (2017-2022)
    Table 34. Global Low Molecular Weight Heparin Sodium Revenue Share by Type (2023-2028)
    Table 35. Low Molecular Weight Heparin Sodium Price by Type (2017-2022) & (USD/MT)
    Table 36. Global Low Molecular Weight Heparin Sodium Price Forecast by Type (2023-2028) & (USD/MT)
    Table 37. Global Low Molecular Weight Heparin Sodium Sales by Application (2017-2022) & (K MT)
    Table 38. Global Low Molecular Weight Heparin Sodium Sales by Application (2023-2028) & (K MT)
    Table 39. Global Low Molecular Weight Heparin Sodium Sales Share by Application (2017-2022)
    Table 40. Global Low Molecular Weight Heparin Sodium Sales Share by Application (2023-2028)
    Table 41. Global Low Molecular Weight Heparin Sodium Revenue by Application (2017-2022) & (US$ Million)
    Table 42. Global Low Molecular Weight Heparin Sodium Revenue by Application (2023-2028) & (US$ Million)
    Table 43. Global Low Molecular Weight Heparin Sodium Revenue Share by Application (2017-2022)
    Table 44. Global Low Molecular Weight Heparin Sodium Revenue Share by Application (2023-2028)
    Table 45. Low Molecular Weight Heparin Sodium Price by Application (2017-2022) & (USD/MT)
    Table 46. Global Low Molecular Weight Heparin Sodium Price Forecast by Application (2023-2028) & (USD/MT)
    Table 47. North America Low Molecular Weight Heparin Sodium Sales by Type (2017-2022) & (K MT)
    Table 48. North America Low Molecular Weight Heparin Sodium Sales by Type (2023-2028) & (K MT)
    Table 49. North America Low Molecular Weight Heparin Sodium Revenue by Type (2017-2022) & (US$ Million)
    Table 50. North America Low Molecular Weight Heparin Sodium Revenue by Type (2023-2028) & (US$ Million)
    Table 51. North America Low Molecular Weight Heparin Sodium Sales by Application (2017-2022) & (K MT)
    Table 52. North America Low Molecular Weight Heparin Sodium Sales by Application (2023-2028) & (K MT)
    Table 53. North America Low Molecular Weight Heparin Sodium Revenue by Application (2017-2022) & (US$ Million)
    Table 54. North America Low Molecular Weight Heparin Sodium Revenue by Application (2023-2028) & (US$ Million)
    Table 55. North America Low Molecular Weight Heparin Sodium Sales by Country (2017-2022) & (K MT)
    Table 56. North America Low Molecular Weight Heparin Sodium Sales by Country (2023-2028) & (K MT)
    Table 57. North America Low Molecular Weight Heparin Sodium Revenue by Country (2017-2022) & (US$ Million)
    Table 58. North America Low Molecular Weight Heparin Sodium Revenue by Country (2023-2028) & (US$ Million)
    Table 59. Europe Low Molecular Weight Heparin Sodium Sales by Type (2017-2022) & (K MT)
    Table 60. Europe Low Molecular Weight Heparin Sodium Sales by Type (2023-2028) & (K MT)
    Table 61. Europe Low Molecular Weight Heparin Sodium Revenue by Type (2017-2022) & (US$ Million)
    Table 62. Europe Low Molecular Weight Heparin Sodium Revenue by Type (2023-2028) & (US$ Million)
    Table 63. Europe Low Molecular Weight Heparin Sodium Sales by Application (2017-2022) & (K MT)
    Table 64. Europe Low Molecular Weight Heparin Sodium Sales by Application (2023-2028) & (K MT)
    Table 65. Europe Low Molecular Weight Heparin Sodium Revenue by Application (2017-2022) & (US$ Million)
    Table 66. Europe Low Molecular Weight Heparin Sodium Revenue by Application (2023-2028) & (US$ Million)
    Table 67. Europe Low Molecular Weight Heparin Sodium Sales by Country (2017-2022) & (K MT)
    Table 68. Europe Low Molecular Weight Heparin Sodium Sales by Country (2023-2028) & (K MT)
    Table 69. Europe Low Molecular Weight Heparin Sodium Revenue by Country (2017-2022) & (US$ Million)
    Table 70. Europe Low Molecular Weight Heparin Sodium Revenue by Country (2023-2028) & (US$ Million)
    Table 71. Asia Pacific Low Molecular Weight Heparin Sodium Sales by Type (2017-2022) & (K MT)
    Table 72. Asia Pacific Low Molecular Weight Heparin Sodium Sales by Type (2023-2028) & (K MT)
    Table 73. Asia Pacific Low Molecular Weight Heparin Sodium Revenue by Type (2017-2022) & (US$ Million)
    Table 74. Asia Pacific Low Molecular Weight Heparin Sodium Revenue by Type (2023-2028) & (US$ Million)
    Table 75. Asia Pacific Low Molecular Weight Heparin Sodium Sales by Application (2017-2022) & (K MT)
    Table 76. Asia Pacific Low Molecular Weight Heparin Sodium Sales by Application (2023-2028) & (K MT)
    Table 77. Asia Pacific Low Molecular Weight Heparin Sodium Revenue by Application (2017-2022) & (US$ Million)
    Table 78. Asia Pacific Low Molecular Weight Heparin Sodium Revenue by Application (2023-2028) & (US$ Million)
    Table 79. Asia Pacific Low Molecular Weight Heparin Sodium Sales by Region (2017-2022) & (K MT)
    Table 80. Asia Pacific Low Molecular Weight Heparin Sodium Sales by Region (2023-2028) & (K MT)
    Table 81. Asia Pacific Low Molecular Weight Heparin Sodium Revenue by Region (2017-2022) & (US$ Million)
    Table 82. Asia Pacific Low Molecular Weight Heparin Sodium Revenue by Region (2023-2028) & (US$ Million)
    Table 83. Latin America Low Molecular Weight Heparin Sodium Sales by Type (2017-2022) & (K MT)
    Table 84. Latin America Low Molecular Weight Heparin Sodium Sales by Type (2023-2028) & (K MT)
    Table 85. Latin America Low Molecular Weight Heparin Sodium Revenue by Type (2017-2022) & (US$ Million)
    Table 86. Latin America Low Molecular Weight Heparin Sodium Revenue by Type (2023-2028) & (US$ Million)
    Table 87. Latin America Low Molecular Weight Heparin Sodium Sales by Application (2017-2022) & (K MT)
    Table 88. Latin America Low Molecular Weight Heparin Sodium Sales by Application (2023-2028) & (K MT)
    Table 89. Latin America Low Molecular Weight Heparin Sodium Revenue by Application (2017-2022) & (US$ Million)
    Table 90. Latin America Low Molecular Weight Heparin Sodium Revenue by Application (2023-2028) & (US$ Million)
    Table 91. Latin America Low Molecular Weight Heparin Sodium Sales by Country (2017-2022) & (K MT)
    Table 92. Latin America Low Molecular Weight Heparin Sodium Sales by Country (2023-2028) & (K MT)
    Table 93. Latin America Low Molecular Weight Heparin Sodium Revenue by Country (2017-2022) & (US$ Million)
    Table 94. Latin America Low Molecular Weight Heparin Sodium Revenue by Country (2023-2028) & (US$ Million)
    Table 95. Middle East and Africa Low Molecular Weight Heparin Sodium Sales by Type (2017-2022) & (K MT)
    Table 96. Middle East and Africa Low Molecular Weight Heparin Sodium Sales by Type (2023-2028) & (K MT)
    Table 97. Middle East and Africa Low Molecular Weight Heparin Sodium Revenue by Type (2017-2022) & (US$ Million)
    Table 98. Middle East and Africa Low Molecular Weight Heparin Sodium Revenue by Type (2023-2028) & (US$ Million)
    Table 99. Middle East and Africa Low Molecular Weight Heparin Sodium Sales by Application (2017-2022) & (K MT)
    Table 100. Middle East and Africa Low Molecular Weight Heparin Sodium Sales by Application (2023-2028) & (K MT)
    Table 101. Middle East and Africa Low Molecular Weight Heparin Sodium Revenue by Application (2017-2022) & (US$ Million)
    Table 102. Middle East and Africa Low Molecular Weight Heparin Sodium Revenue by Application (2023-2028) & (US$ Million)
    Table 103. Middle East and Africa Low Molecular Weight Heparin Sodium Sales by Country (2017-2022) & (K MT)
    Table 104. Middle East and Africa Low Molecular Weight Heparin Sodium Sales by Country (2023-2028) & (K MT)
    Table 105. Middle East and Africa Low Molecular Weight Heparin Sodium Revenue by Country (2017-2022) & (US$ Million)
    Table 106. Middle East and Africa Low Molecular Weight Heparin Sodium Revenue by Country (2023-2028) & (US$ Million)
    Table 107. Aspen Corporation Information
    Table 108. Aspen Description and Major Businesses
    Table 109. Aspen Low Molecular Weight Heparin Sodium Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 110. Aspen Low Molecular Weight Heparin Sodium Product Model Numbers, Pictures, Descriptions and Specifications
    Table 111. Aspen Recent Developments
    Table 112. Sanofi-aventis Corporation Information
    Table 113. Sanofi-aventis Description and Major Businesses
    Table 114. Sanofi-aventis Low Molecular Weight Heparin Sodium Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 115. Sanofi-aventis Low Molecular Weight Heparin Sodium Product Model Numbers, Pictures, Descriptions and Specifications
    Table 116. Sanofi-aventis Recent Developments
    Table 117. Pfizer Corporation Information
    Table 118. Pfizer Description and Major Businesses
    Table 119. Pfizer Low Molecular Weight Heparin Sodium Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 120. Pfizer Low Molecular Weight Heparin Sodium Product Model Numbers, Pictures, Descriptions and Specifications
    Table 121. Pfizer Recent Developments
    Table 122. Opocrin Corporation Information
    Table 123. Opocrin Description and Major Businesses
    Table 124. Opocrin Low Molecular Weight Heparin Sodium Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 125. Opocrin Low Molecular Weight Heparin Sodium Product Model Numbers, Pictures, Descriptions and Specifications
    Table 126. Opocrin Recent Developments
    Table 127. CSBIO Corporation Information
    Table 128. CSBIO Description and Major Businesses
    Table 129. CSBIO Low Molecular Weight Heparin Sodium Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 130. CSBIO Low Molecular Weight Heparin Sodium Product Model Numbers, Pictures, Descriptions and Specifications
    Table 131. CSBIO Recent Developments
    Table 132. Dongying Tiandong Pharmaceutica Corporation Information
    Table 133. Dongying Tiandong Pharmaceutica Description and Major Businesses
    Table 134. Dongying Tiandong Pharmaceutica Low Molecular Weight Heparin Sodium Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 135. Dongying Tiandong Pharmaceutica Low Molecular Weight Heparin Sodium Product Model Numbers, Pictures, Descriptions and Specifications
    Table 136. Dongying Tiandong Pharmaceutica Recent Developments
    Table 137. Changzhou Qianhong Bio-pharma Corporation Information
    Table 138. Changzhou Qianhong Bio-pharma Description and Major Businesses
    Table 139. Changzhou Qianhong Bio-pharma Low Molecular Weight Heparin Sodium Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 140. Changzhou Qianhong Bio-pharma Low Molecular Weight Heparin Sodium Product Model Numbers, Pictures, Descriptions and Specifications
    Table 141. Changzhou Qianhong Bio-pharma Recent Developments
    Table 142. Techdow Corporation Information
    Table 143. Techdow Description and Major Businesses
    Table 144. Techdow Low Molecular Weight Heparin Sodium Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 145. Techdow Low Molecular Weight Heparin Sodium Product Model Numbers, Pictures, Descriptions and Specifications
    Table 146. Techdow Recent Developments
    Table 147. Yantai Dongcheng Pharmaceutical Group Corporation Information
    Table 148. Yantai Dongcheng Pharmaceutical Group Description and Major Businesses
    Table 149. Yantai Dongcheng Pharmaceutical Group Low Molecular Weight Heparin Sodium Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 150. Yantai Dongcheng Pharmaceutical Group Low Molecular Weight Heparin Sodium Product Model Numbers, Pictures, Descriptions and Specifications
    Table 151. Yantai Dongcheng Pharmaceutical Group Recent Developments
    Table 152. Key Raw Materials Lists
    Table 153. Raw Materials Key Suppliers Lists
    Table 154. Low Molecular Weight Heparin Sodium Distributors List
    Table 155. Low Molecular Weight Heparin Sodium Customers List
    Table 156. Low Molecular Weight Heparin Sodium Market Trends
    Table 157. Low Molecular Weight Heparin Sodium Market Drivers
    Table 158. Low Molecular Weight Heparin Sodium Market Challenges
    Table 159. Low Molecular Weight Heparin Sodium Market Restraints
    Table 160. Research Programs/Design for This Report
    Table 161. Key Data Information from Secondary Sources
    Table 162. Key Data Information from Primary Sources
List of Figures
    Figure 1. Low Molecular Weight Heparin Sodium Product Picture
    Figure 3. Global Low Molecular Weight Heparin Sodium Market Share by Type in 2021 & 2028
    Figure 3. Enoxaparin Product Picture
    Figure 4. Dalteparin Product Picture
    Figure 5. Tinzaparin Product Picture
    Figure 6. Fraxiparine Product Picture
    Figure 7. Global Low Molecular Weight Heparin Sodium Market Share by Application in 2021 & 2028
    Figure 8. Medical
    Figure 9. Research
    Figure 10. Low Molecular Weight Heparin Sodium Report Years Considered
    Figure 11. Global Low Molecular Weight Heparin Sodium Sales 2017-2028 (K MT)
    Figure 12. Global Low Molecular Weight Heparin Sodium Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Low Molecular Weight Heparin Sodium Revenue 2017-2028 (US$ Million)
    Figure 14. Global Low Molecular Weight Heparin Sodium Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 15. Global Low Molecular Weight Heparin Sodium Sales Market Share by Region (2017-2022)
    Figure 16. Global Low Molecular Weight Heparin Sodium Sales Market Share by Region (2023-2028)
    Figure 17. North America Low Molecular Weight Heparin Sodium Sales YoY (2017-2028) & (K MT)
    Figure 18. North America Low Molecular Weight Heparin Sodium Revenue YoY (2017-2028) & (US$ Million)
    Figure 19. Europe Low Molecular Weight Heparin Sodium Sales YoY (2017-2028) & (K MT)
    Figure 20. Europe Low Molecular Weight Heparin Sodium Revenue YoY (2017-2028) & (US$ Million)
    Figure 21. Asia-Pacific Low Molecular Weight Heparin Sodium Sales YoY (2017-2028) & (K MT)
    Figure 22. Asia-Pacific Low Molecular Weight Heparin Sodium Revenue YoY (2017-2028) & (US$ Million)
    Figure 23. Latin America Low Molecular Weight Heparin Sodium Sales YoY (2017-2028) & (K MT)
    Figure 24. Latin America Low Molecular Weight Heparin Sodium Revenue YoY (2017-2028) & (US$ Million)
    Figure 25. Middle East & Africa Low Molecular Weight Heparin Sodium Sales YoY (2017-2028) & (K MT)
    Figure 26. Middle East & Africa Low Molecular Weight Heparin Sodium Revenue YoY (2017-2028) & (US$ Million)
    Figure 27. The Low Molecular Weight Heparin Sodium Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 28. The Top 5 and 10 Largest Manufacturers of Low Molecular Weight Heparin Sodium in the World: Market Share by Low Molecular Weight Heparin Sodium Revenue in 2021
    Figure 29. Global Low Molecular Weight Heparin Sodium Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 30. Global Low Molecular Weight Heparin Sodium Sales Market Share by Type (2017-2028)
    Figure 31. Global Low Molecular Weight Heparin Sodium Revenue Market Share by Type (2017-2028)
    Figure 32. Global Low Molecular Weight Heparin Sodium Sales Market Share by Application (2017-2028)
    Figure 33. Global Low Molecular Weight Heparin Sodium Revenue Market Share by Application (2017-2028)
    Figure 34. North America Low Molecular Weight Heparin Sodium Sales Market Share by Type (2017-2028)
    Figure 35. North America Low Molecular Weight Heparin Sodium Revenue Market Share by Type (2017-2028)
    Figure 36. North America Low Molecular Weight Heparin Sodium Sales Market Share by Application (2017-2028)
    Figure 37. North America Low Molecular Weight Heparin Sodium Revenue Market Share by Application (2017-2028)
    Figure 38. North America Low Molecular Weight Heparin Sodium Sales Share by Country (2017-2028)
    Figure 39. North America Low Molecular Weight Heparin Sodium Revenue Share by Country (2017-2028)
    Figure 40. U.S. Low Molecular Weight Heparin Sodium Revenue (2017-2028) & (US$ Million)
    Figure 41. Canada Low Molecular Weight Heparin Sodium Revenue (2017-2028) & (US$ Million)
    Figure 42. Europe Low Molecular Weight Heparin Sodium Sales Market Share by Type (2017-2028)
    Figure 43. Europe Low Molecular Weight Heparin Sodium Revenue Market Share by Type (2017-2028)
    Figure 44. Europe Low Molecular Weight Heparin Sodium Sales Market Share by Application (2017-2028)
    Figure 45. Europe Low Molecular Weight Heparin Sodium Revenue Market Share by Application (2017-2028)
    Figure 46. Europe Low Molecular Weight Heparin Sodium Sales Share by Country (2017-2028)
    Figure 47. Europe Low Molecular Weight Heparin Sodium Revenue Share by Country (2017-2028)
    Figure 48. Germany Low Molecular Weight Heparin Sodium Revenue (2017-2028) & (US$ Million)
    Figure 49. France Low Molecular Weight Heparin Sodium Revenue (2017-2028) & (US$ Million)
    Figure 50. U.K. Low Molecular Weight Heparin Sodium Revenue (2017-2028) & (US$ Million)
    Figure 51. Italy Low Molecular Weight Heparin Sodium Revenue (2017-2028) & (US$ Million)
    Figure 52. Russia Low Molecular Weight Heparin Sodium Revenue (2017-2028) & (US$ Million)
    Figure 53. Asia Pacific Low Molecular Weight Heparin Sodium Sales Market Share by Type (2017-2028)
    Figure 54. Asia Pacific Low Molecular Weight Heparin Sodium Revenue Market Share by Type (2017-2028)
    Figure 55. Asia Pacific Low Molecular Weight Heparin Sodium Sales Market Share by Application (2017-2028)
    Figure 56. Asia Pacific Low Molecular Weight Heparin Sodium Revenue Market Share by Application (2017-2028)
    Figure 57. Asia Pacific Low Molecular Weight Heparin Sodium Sales Share by Region (2017-2028)
    Figure 58. Asia Pacific Low Molecular Weight Heparin Sodium Revenue Share by Region (2017-2028)
    Figure 59. China Low Molecular Weight Heparin Sodium Revenue (2017-2028) & (US$ Million)
    Figure 60. Japan Low Molecular Weight Heparin Sodium Revenue (2017-2028) & (US$ Million)
    Figure 61. South Korea Low Molecular Weight Heparin Sodium Revenue (2017-2028) & (US$ Million)
    Figure 62. India Low Molecular Weight Heparin Sodium Revenue (2017-2028) & (US$ Million)
    Figure 63. Australia Low Molecular Weight Heparin Sodium Revenue (2017-2028) & (US$ Million)
    Figure 64. China Taiwan Low Molecular Weight Heparin Sodium Revenue (2017-2028) & (US$ Million)
    Figure 65. Indonesia Low Molecular Weight Heparin Sodium Revenue (2017-2028) & (US$ Million)
    Figure 66. Thailand Low Molecular Weight Heparin Sodium Revenue (2017-2028) & (US$ Million)
    Figure 67. Malaysia Low Molecular Weight Heparin Sodium Revenue (2017-2028) & (US$ Million)
    Figure 68. Latin America Low Molecular Weight Heparin Sodium Sales Market Share by Type (2017-2028)
    Figure 69. Latin America Low Molecular Weight Heparin Sodium Revenue Market Share by Type (2017-2028)
    Figure 70. Latin America Low Molecular Weight Heparin Sodium Sales Market Share by Application (2017-2028)
    Figure 71. Latin America Low Molecular Weight Heparin Sodium Revenue Market Share by Application (2017-2028)
    Figure 72. Latin America Low Molecular Weight Heparin Sodium Sales Share by Country (2017-2028)
    Figure 73. Latin America Low Molecular Weight Heparin Sodium Revenue Share by Country (2017-2028)
    Figure 74. Mexico Low Molecular Weight Heparin Sodium Revenue (2017-2028) & (US$ Million)
    Figure 75. Brazil Low Molecular Weight Heparin Sodium Revenue (2017-2028) & (US$ Million)
    Figure 76. Argentina Low Molecular Weight Heparin Sodium Revenue (2017-2028) & (US$ Million)
    Figure 77. Middle East and Africa Low Molecular Weight Heparin Sodium Sales Market Share by Type (2017-2028)
    Figure 78. Middle East and Africa Low Molecular Weight Heparin Sodium Revenue Market Share by Type (2017-2028)
    Figure 79. Middle East and Africa Low Molecular Weight Heparin Sodium Sales Market Share by Application (2017-2028)
    Figure 80. Middle East and Africa Low Molecular Weight Heparin Sodium Revenue Market Share by Application (2017-2028)
    Figure 81. Middle East and Africa Low Molecular Weight Heparin Sodium Sales Share by Country (2017-2028)
    Figure 82. Middle East and Africa Low Molecular Weight Heparin Sodium Revenue Share by Country (2017-2028)
    Figure 83. Turkey Low Molecular Weight Heparin Sodium Revenue (2017-2028) & (US$ Million)
    Figure 84. Saudi Arabia Low Molecular Weight Heparin Sodium Revenue (2017-2028) & (US$ Million)
    Figure 85. UAE Low Molecular Weight Heparin Sodium Revenue (2017-2028) & (US$ Million)
    Figure 86. Low Molecular Weight Heparin Sodium Value Chain
    Figure 87. Low Molecular Weight Heparin Sodium Production Process
    Figure 88. Channels of Distribution
    Figure 89. Distributors Profiles
    Figure 90. Bottom-up and Top-down Approaches for This Report
    Figure 91. Data Triangulation
    Figure 92. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Aspen
Sanofi-aventis
Pfizer
Opocrin
CSBIO
Dongying Tiandong Pharmaceutica
Changzhou Qianhong Bio-pharma
Techdow
Yantai Dongcheng Pharmaceutical Group
Frequently Asked Questions
Low Molecular Weight Heparin Sodium report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Low Molecular Weight Heparin Sodium report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Low Molecular Weight Heparin Sodium report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Digital Out of Home

Digital Out of Home market is segmented by Type and by Application. Players, stakeholders, and ot ... Read More

AFCI Receptacle

AFCI Receptacle market is segmented by Type and by Application. Players, stakeholders, and other  ... Read More